NEM vs VRCA · P/E 14, rev $13.43B vs rev $10.9M
Newmont Goldcorp Corp (NEM) versus Verrica Pharmaceuticals Inc (VRCA) — a side-by-side from cached financials, not a winner call.
Newmont Goldcorp Corp (NEM) is a gold company listed on NYSE.
Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.
Latest reported NEM revenue for 2026-06-30 was $13.43B. Net income was $5.46B. Revenue was up 83.7% from 2026-03-31 to 2026-06-30. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
Latest reported VRCA revenue for 2026-06-30 was $10.9M. Net income was -$22.8M. VRCA currently screens at market cap $79.7M.
NEM currently screens at market cap $112.81B and trailing P/E 13.7. VRCA currently screens at market cap $79.7M.
Not investment advice. Open the NEM and VRCA stock pages for the full models.
Not investment advice.